Qorium
Qorium is the world’s leading cell-cultured leather company, having successfully produced a pioneering proof of concept product in 2021. Qorium’s leather comes with dramatically reduced carbon emissions, no methane emissions and radically reduced water and chemical use compared to traditional leather, with no ties to the livestock industry or the polluting processes necessary in the processing of animal hides.
Sector
Industrial Biotech
Strategy
Industrial Biotech
Status
Live
Website
www.qorium.com
Related News
Qorium bolsters Board with appointment of Elizabeth Bastoni and Martin Brok, renowned experts in the consumer goods and retail sectors
Qorium lands additional funds from Brightlands Venture Partners and Sofinnova Partners, as the company sets out on an ambitious growth drive for sustainable leather with the appointment of CEO Michael Newton
The Sofinnova Capital Strategy acts as a founding and lead investor in early-stage biopharma and medtech start-ups focusing on groundbreaking therapeutic technologies.
The MD Start Strategy is Sofinnova’s in-house medtech accelerator. The team’s hands-on entrepreneurial expertise contributes to the platform's global leadership in company building.
The Sofinnova Crossover Strategy supports ground-breaking innovations in later-stage biotech and medtech companies, enabling ambitious life sciences companies to reach their full potential.
Our Industrial Biotech Strategy seeks early-stage investments that will have a positive impact on sustainability in the chemicals, agriculture, food and materials sectors.
The Sofinnova Telethon Strategy seeks early-stage projects to bring the best Italian science to the world stage.
The Sofinnova Digital Medicine Strategy backs early-stage startups at the intersection of biology, data and computation.
The Sofinnova Biovelocita Strategy is dedicated entirely to the creation and acceleration of European biotech startups, in partnership with leading research organizations.